These results indicate that miRNA-148a mediates the protective effect of HHP-EXO against myocardial hypertrophy via down-regulation of GP130, leading to the inhibition of STAT3, ERK1/2, and AKT signaling pathways (Fig. 7). Here, MAPK3 is linked to cardiac hypertrophy.